Antinuclear Antibody Test Market - Forecast(2020 - 2025)

Report Code: HCR 0528 Report Format: PDF + Excel (Delivery in 48 Hrs)

Overview

Antinuclear Antibody Test Market is projected to reach revenue of $2.35billion by 2025, and is estimated to grow at a CAGR of 12.4% during the forecast period 2019-2025. The Antinuclear Antibody test market size, in 2018, is $1.04 billion. Antinuclear Antibody tests are done to evaluate an individual for autoimmune disorders.  Antinuclear antibodies (ANA) are produced as an immune response to foreign bodies. Sometimes these ANAs attack the cells within the body which leads to autoimmune disorders such as lupus, scleroderma, and rheumatoid arthritis. These ANAs are also called autoantibodies.

Key Takeaways

  • The market is estimated to grow at a CAGR of 12.4%. With rising prevalence of autoimmune disorders, antinuclear antibody testing has also risen.
  • Rising awareness and availability of range of diagnostic tools contribute to the growth in this market. Advances in technology and increasing investment in healthcare is also driving the market.

Test Product - Segment Analysis

Reagent assay kits occupy the largest share in the antinuclear antibody test market. Laboratories commonly use reagent assay kits to test for antibodies. These reagent assays are popularly used as they are convenient, efficient, and accurate.

Test Technique - Segment Analysis

As per the technique of antinuclear antibody test, ELISA (enzyme linked immunosorbent assay) has the major share. This is due to the frequent use of this test for autoimmune disorder tests. It detects and measures the antibodies from blood and hence is convenient. ELISA is commonly used for detecting diseases such as HIV, Lyme disease, and others.

Test Application - Segment Analysis

Rheumatoid arthritis segment is estimated to have the largest share by test application and is growing at a CAGR of 9.70%. This disease is highly prevalent and affects mostly those within the age group of 35-50. Women are more likely to get this disease as compared to men.

Test End-Use - Segment Analysis

The hospital segment is said to have the highest share by test end-use. Hospitals are most frequented by patients and thus a large number of tests are being conducted here compared to clinics and laboratories. 

Geography - Segment Analysis

North America accounts for largest Antinuclear Antibody test market share with 35% in 2018. According to the American Autoimmune Related Diseases Association, 50 million Americans have Autoimmune Diseases. This huge number is said to contribute to growth in the antinuclear antibody test market as larger number of tests will be done by these patients.

Drivers – Antinuclear Antibody Test Market

  • Rising prevalence of autoimmune diseases globally

Antibodies protect body by strengthening the immune system. However, if a test detects antinuclear antibodies in the body of an individual, it could mean that the person has an autoimmune disorder. An antinuclear antibodies test is used to help diagnose autoimmune disorders. As per the National Institutes of Health, about 23.5 million Americans are affected by autoimmune diseases. Also, the Connect Immune Research reports that costs for just 3 autoimmune diseases, namely, type 1 diabetes, rheumatoid arthritis and multiple sclerosis, add up to more than £13 billion per year in UK. Rising incidence of autoimmune disease have led to growth of the antinuclear antibody test market.

  • Advances in technology and research developments

Discovery of biomarkers and laboratory automation is also said to drive the market. Biomarkers are useful in identifying the diseases type, progression and more. Thus they are useful in developing tests for the autoimmune diseases. Also with rising autoimmune diseases, a number of samples are being used in their tests. Thus laboratory automation is also crucial in handling these samples with accuracy and efficiency.

Antinuclear Antibody Test Industry Outlook

Research & development along with strategic alliances are some of the key strategies adopted by players in the Antinuclear Antibody test market. Antinuclear Antibody Test Market top 10 companies are Alere Inc., Bio-Rad Laboratories, Inc., ERBA Diagnostics, Inc., Trinity Biotech plc, Thermo Fisher Scientific, Inc., Antibodies, Inc., Inova Diagnostics, Zeus Scientific, Inc., F. Hoffmann-La Roche Ltd., and Becton Dickinson and Company.

Antinuclear Antibody Test Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Antinuclear Antibody Test Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. 

1. Antinuclear Antibody Test Market - Market Overview
    1.1  Definitions and Scope
2. Antinuclear Antibody Test Market - Executive Summary
    2.1 Market Size and Key Trends 
    2.2 Key trends by Application
    2.3 Key trends by Geography
3. Antinuclear Antibody Test Market – Comparative Analysis
    3.1 Product Benchmarking Key Companies
    3.2 Top 5 Financial Analysis
    3.3 Patent Analysis
    3.4 Pricing Analysis
4. Antinuclear Antibody Test Market – Startup companies Scenario Premium (Premium)
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Market Size and Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Antinuclear Antibody Test Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case studies of successful ventures
    5.4 Customer Analysis – Key companies 
6. Antinuclear Antibody Test Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Antinuclear Antibody Test Market - Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunity Analysis
    7.3 Market Life Cycle
8. Antinuclear Antibody Test Market – By Test Product (Market Size -$Million/$Billion)
    8.1 Reagent Assay Kits
    8.2 Systems
    8.3 Software Services
9. Antinuclear Antibody Test Market – By Test Technique (Market Size -$Million/$Billion)
    9.1 ELISA
    9.2 Immunofluorescence Assay
    9.3 Multiple Assay
10. Antinuclear Antibody Test Market – By Test Application (Market Size -$Million/$Billion)
    10.1 Rheumatoid Arthritis
    10.2 Systemic Lupus Erythematosus
    10.3 Sjogren’s Syndrome
    10.4 Scleroderma
    10.5 Others
11. Antinuclear Antibody Test Market – By Test End-Use (Market Size -$Million/$Billion)
    11.1 Hospitals
    11.2 Clinical Laboratories
    11.3 Physician Office Laboratories
    11.4 Others
12. Antinuclear Antibody Test Market – By Geography (Market Size -$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France 
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Australia 
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 India
        12.3.6 Rest of Asia Pacific
    12.4 RoW
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Antinuclear Antibody Test Market – Entropy
14. Antinuclear Antibody Test Market - Industry / Segment Competition landscape Premium (Premium)
    14.1 Market Share Analysis
        14.1.1 Market Share by Country- Key companies
        14.1.2 Market Share by Region- Key companies
        14.1.3 Market Share at Global level- Key companies
        14.1.4 Best Practices for companies
15. Antinuclear Antibody Test Market - Key Company List by Country Premium (Premium)
16. Antinuclear Antibody Test Market - Company Analysis
    16.1 Market Share, Company Revenue, Products, M&A, Developments
        16.1.1 Company 1
        16.1.2 Company 2
        16.1.3 Company 3
        16.1.4 Company 4
        16.1.5 Company 5
        16.1.6 Company 6
        16.1.7 Company 7
        16.1.8 Company 8
        16.1.9 Company 9
        16.1.10 Company 10 and more
"*Financials of the private companies would be provided on a best efforts basis”